15 Oct 2020
BioStock Live Event
Event
CEO Sten R. Sörensen will present the company with its revised clinical strategy for CS1 in rare disease PAH at BioStock Live on October 15, at 11.00 CET.
15 Oct 2020
CEO Sten R. Sörensen will present the company with its revised clinical strategy for CS1 in rare disease PAH at BioStock Live on October 15, at 11.00 CET.